Literature DB >> 17606730

An imageable metastatic treatment model of nasopharyngeal carcinoma.

Tengfei Liu1, Yanqin Ding, Weibing Xie, Zuguo Li, Xiaoyan Bai, Xin Li, Weiyi Fang, Caiping Ren, Shuang Wang, Robert M Hoffman, Kaitai Yao.   

Abstract

PURPOSE: Nasopharyngeal carcinoma is highly prevalent in southern China and is often resistant to current treatment options. EXPERIMENTAL
DESIGN: Clinically relevant mouse models are necessary for further understanding and drug discovery in this disease. Two nasopharyngeal carcinoma cell lines, stably expressing green fluorescent protein (GFP), 5-8F-GFP and 6-10B-GFP, were established. The cells were orthotopically injected into the nasopharynx or ectopically into the subcutis of nude mice. Whole-body fluorescence imaging was used to monitor the growth of the primary tumor as well as angiogenesis and metastasis.
RESULTS: The metastatic behavior of 5-8F and 6-10B were distinct in the orthotopic model. Orthotopic implantation of highly metastatic 5-8F cells resulted in brain invasion, cervical lymph node metastases, and pulmonary metastases similar to what is often observed in patients. Cell line 6-10B was less metastatic, which occasionally resulted in pulmonary metastasis. GFP enabled imaging of micrometastasis. Neither 5-8F nor 6-10B were metastatic in the s.c. site. These results indicated that, in addition to the cancer cell type, the host microenvironment was critical for metastasis to occur consistent with the "seed-and-soil" hypothesis. 5-8F was highly sensitive to 5-fluorouracil (5-FU), whereas 6-10B was moderately sensitive.
CONCLUSIONS: The imageable orthotopic model should play a critical role in elucidating the mechanisms involved in the growth, progression, metastasis, and angiogenesis of nasopharyngeal carcinoma and for evaluation of novel compounds with potential efficacy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606730     DOI: 10.1158/1078-0432.CCR-07-0089

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  17 in total

1.  An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis.

Authors:  Pamela A Smith; David Merritt; Leah Barr; David A Thorley-Lawson
Journal:  Genes Cancer       Date:  2011-11

Review 2.  New cast for a new era: preclinical cancer drug development revisited.

Authors:  Grit S Herter-Sprie; Andrew L Kung; Kwok-Kin Wong
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 3.  Non-invasive molecular imaging for preclinical cancer therapeutic development.

Authors:  A C O'Farrell; S D Shnyder; G Marston; P L Coletta; J H Gill
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

4.  TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness.

Authors:  Xiaoming Lyu; Weiyi Fang; Longmei Cai; Hang Zheng; Yanfen Ye; Lan Zhang; Jinbang Li; Hong Peng; William C S Cho; Ena Wang; Francesco M Marincola; Kaitai Yao; Hongbing Cai; Jiliang Li; Xin Li
Journal:  Mol Cancer       Date:  2014-03-08       Impact factor: 27.401

5.  Modeling nasopharyngeal carcinoma in three dimensions.

Authors:  Prabu Siva Sankar; Mohd Firdaus Che Mat; Kalaivani Muniandy; Benedict Lian Shi Xiang; Phang Su Ling; Susan Ling Ling Hoe; Alan Soo-Beng Khoo; Nethia Mohana-Kumaran
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

6.  Over-expression of eukaryotic translation initiation factor 4 gamma 1 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.

Authors:  Luxia Tu; Zhen Liu; Xiufang He; Ying He; Huiling Yang; Qingping Jiang; Siming Xie; Guanghui Xiao; Xin Li; Kaitai Yao; Weiyi Fang
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

7.  A Non-invasive Imageable GFP-expressing Mouse Model of Orthotopic Human Bladder Cancer.

Authors:  Y U Sun; Hiroto Nishino; Ming Zhao; Kentaro Miyake; Norihiko Sugisawa; Jun Yamamoto; Yoshihiko Tashiro; Sachiko Inubushi; Kazuyuki Hamada; Guangwei Zhu; Hyein Lim; Robert M Hoffman
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.

Authors:  Yufang Zuo; Jiangxue Wu; Zumin Xu; Shiping Yang; Haijiao Yan; Li Tan; Xiangqi Meng; Xiaofang Ying; Ranyi Liu; Tiebang Kang; Wenlin Huang
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

Review 9.  A Review: Proteomics in Nasopharyngeal Carcinoma.

Authors:  Ze-Tan Chen; Zhong-Guo Liang; Xiao-Dong Zhu
Journal:  Int J Mol Sci       Date:  2015-07-08       Impact factor: 5.923

10.  miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2.

Authors:  Li Yu; Juan Lu; Bao Zhang; Xiong Liu; Lu Wang; Si-Yang Li; Xiao-Hong Peng; Xia Xu; Wen-Dong Tian; Xiang-Ping Li
Journal:  Oncol Lett       Date:  2013-02-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.